DOCOSANOL and INCORRECT PRODUCT ADMINISTRATION DURATION

637 reports of this reaction

2.4% of all DOCOSANOL reports

#7 most reported adverse reaction

Overview

INCORRECT PRODUCT ADMINISTRATION DURATION is the #7 most commonly reported adverse reaction for DOCOSANOL, manufactured by Haleon US Holdings LLC. There are 637 FDA adverse event reports linking DOCOSANOL to INCORRECT PRODUCT ADMINISTRATION DURATION. This represents approximately 2.4% of all 26,055 adverse event reports for this drug.

Patients taking DOCOSANOL who experience incorrect product administration duration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INCORRECT PRODUCT ADMINISTRATION DURATION637 of 26,055 reports

INCORRECT PRODUCT ADMINISTRATION DURATION is a less commonly reported adverse event for DOCOSANOL, but still significant enough to appear in the safety profile.

Other Side Effects of DOCOSANOL

In addition to incorrect product administration duration, the following adverse reactions have been reported for DOCOSANOL:

Other Drugs Associated with INCORRECT PRODUCT ADMINISTRATION DURATION

The following drugs have also been linked to incorrect product administration duration in FDA adverse event reports:

ETONOGESTRELGLYCERIN, LIDOCAINEGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDEINSTALAX POLYETHYLENE GLYCOL 3350LOPERAMIDE HCLLOPERAMIDE HYDROCHLORIDE ORALOMEPRAZOLE, SODIUM BICARBONATEPOLYETHYLENE GLYCOL 3350POLYETHYLENE GLYCOL 400TASIMELTEON

Frequently Asked Questions

Does DOCOSANOL cause INCORRECT PRODUCT ADMINISTRATION DURATION?

INCORRECT PRODUCT ADMINISTRATION DURATION has been reported as an adverse event in 637 FDA reports for DOCOSANOL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INCORRECT PRODUCT ADMINISTRATION DURATION with DOCOSANOL?

INCORRECT PRODUCT ADMINISTRATION DURATION accounts for approximately 2.4% of all adverse event reports for DOCOSANOL, making it a notable side effect.

What should I do if I experience INCORRECT PRODUCT ADMINISTRATION DURATION while taking DOCOSANOL?

If you experience incorrect product administration duration while taking DOCOSANOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

DOCOSANOL Full ProfileAll Drugs Causing INCORRECT PRODUCT ADMINISTRATION DURATIONHaleon US Holdings LLC Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.